Montelukast and fluticasone propionate.
Nathan
Robert
R
D000085:Acetates / Q000627:therapeutic use*; D000730:Androstadienes / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D003521:Cyclopropanes; D000068298:Fluticasone; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D010366:Peak Expiratory Flow Rate / Q000187:drug effects / Q000502:physiology; D011804:Quinolines / Q000627:therapeutic use*; D013440:Sulfides
D000085:Acetates; D000730:Androstadienes; D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; D000068298:Fluticasone; C093875:montelukast